Financials data is unavailable for this security.
View more
Year on year Concord Medical Services Holdings Ltd grew revenues 13.84% from 472.09m to 537.40m. Additionally the company has reduced the cost of goods sold, selling, general and administrative expenses and debt expenses (all as percentages of sales). These changes narrowed profitability losses from -489.66m to -297.66m.
| Gross margin | -17.13% |
|---|---|
| Net profit margin | -137.67% |
| Operating margin | -84.66% |
| Return on assets | -10.23% |
|---|---|
| Return on equity | -- |
| Return on investment | -111.95% |
More ▼
Cash flow in CNYView more
In 2023, cash reserves at Concord Medical Services Holdings Ltd fell by 68.92m. Cash Flow from Financing totalled 257.65m or 47.94% of revenues. In addition the company used 276.47m for operations while cash used for investing totalled 47.68m.
| Cash flow per share | -9.02 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | -68.07 |
|---|---|
| Tangible book value per share | -95.85 |
More ▼
Balance sheet in CNYView more
| Current ratio | 0.4739 |
|---|---|
| Quick ratio | 0.4556 |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | 0.6369 |
More ▼
